XTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026

Bulletin Express03-10

XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of Directors.

Mr. Zhou brings more than 12 years of capital-markets and M&A experience in the global healthcare sector. From 2020 to 2026 he served at J.P. Morgan, rising to Executive Director within the Global Healthcare Investment Banking division. Prior roles include Vice President in Global Healthcare Investment Banking at Bank of America Merrill Lynch (2015-2020), as well as positions at a multinational private-equity fund and the advisory division of KPMG Huazhen LLP.

Mr. Zhou holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Finance from Tongji University. He is a Certified Public Accountant (China) and a Chartered Financial Analyst charter-holder.

The Board—comprising Executive Directors Dr. Wen Shuhao (Chairman), Dr. Ma Jian, Dr. Lai Lipeng and Dr. Jiang Yide Alan, and Independent Non-Executive Directors Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki and Mr. Chow Ming Sang—extended a formal welcome to Mr. Zhou on his appointment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138528948?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138528948","market":"us","top_or_hot":-1,"title":"XTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026","media":"Bulletin Express","content":"<p>XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of Directors.</p>\n<p>Mr. Zhou brings more than 12 years of capital-markets and M&A experience in the global healthcare sector. From 2020 to 2026 he served at J.P. Morgan, rising to Executive Director within the Global Healthcare Investment Banking division. Prior roles include Vice President in Global Healthcare Investment Banking at Bank of America Merrill Lynch (2015-2020), as well as positions at a multinational private-equity fund and the advisory division of KPMG Huazhen LLP.</p>\n<p>Mr. Zhou holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Finance from Tongji University. He is a Certified Public Accountant (China) and a Chartered Financial Analyst charter-holder.</p>\n<p>The Board—comprising Executive Directors Dr. Wen Shuhao (Chairman), Dr. Ma Jian, Dr. Lai Lipeng and Dr. Jiang Yide Alan, and Independent Non-Executive Directors Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki and Mr. Chow Ming Sang—extended a formal welcome to Mr. Zhou on his appointment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-10 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of Directors.</p>\n<p>Mr. Zhou brings more than 12 years of capital-markets and M&A experience in the global healthcare sector. From 2020 to 2026 he served at J.P. Morgan, rising to Executive Director within the Global Healthcare Investment Banking division. Prior roles include Vice President in Global Healthcare Investment Banking at Bank of America Merrill Lynch (2015-2020), as well as positions at a multinational private-equity fund and the advisory division of KPMG Huazhen LLP.</p>\n<p>Mr. Zhou holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Finance from Tongji University. He is a Certified Public Accountant (China) and a Chartered Financial Analyst charter-holder.</p>\n<p>The Board—comprising Executive Directors Dr. Wen Shuhao (Chairman), Dr. Ma Jian, Dr. Lai Lipeng and Dr. Jiang Yide Alan, and Independent Non-Executive Directors Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki and Mr. Chow Ming Sang—extended a formal welcome to Mr. Zhou on his appointment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1138528948","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138528948","pubTimestamp":1773140585,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"XTALPI(02228)委任周斐然为首席财务官，2026年3月10日生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of Directors.\nMr. Zhou brings more than 12 years of capital-markets and M&A experience in the global healthcare sector. From 2020 to 2026 he served at J.P. Morgan, rising to Executive Director within the Global Healthcare Investment Banking division. Prior roles include Vice President in Global Healthcare Investment Banking at Bank of America Merrill Lynch (2015-2020), as well as positions at a multinational private-equity fund and the advisory division of KPMG Huazhen LLP.\nMr. Zhou holds an MBA from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Finance from Tongji University. He is a Certified Public Accountant (China) and a Chartered Financial Analyst charter-holder.\nThe Board—comprising Executive Directors Dr. Wen Shuhao (Chairman), Dr. Ma Jian, Dr. Lai Lipeng and Dr. Jiang Yide Alan, and Independent Non-Executive Directors Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki and Mr. Chow Ming Sang—extended a formal welcome to Mr. Zhou on his appointment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138528948","isCrawlerRequest":true}